Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Calne

Showing results (81-90 of 315) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|March 2, 1989
Did Leonardo describe Parkinson's disease?D B Calne, A Dubini, G Stern
Annals of Neurology|December 1, 1992
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomaticM Schulzer, E Mak, D B Calne
Postgraduate Medical Journal|January 1, 1976
An ergot derivative in the treatment of Parkinson's diseaseD B Calne, I Shoulson, R Kartzinel
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1988
Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapyT A Hurwitz, D B Calne, K Waterman
Annals of Neurology|January 1, 1992
Criteria for diagnosing Parkinson's diseaseD B Calne, B J Snow, C Lee
Advances in Neurology|January 1, 1984
Speculations on the etiology of Parkinson's diseaseD B Calne, R C Duvoisin, E McGeer
Archives of Neurology|July 1, 1976
Bromocriptine in Huntington choreaR Kartzinel, R D Hunt, D B Calne
Acta Neurologica Scandinavica|November 1, 1982
Atenolol vs. propranolol in essential tremor. A controlled, quantitative studyT A Larsen, H Teräväinen, D B Calne
Advances in Neurology|January 1, 1988
Botulinum toxin in spasmodic torticollisJ K Tsui, A Eisen, D B Calne
The New England Journal of Medicine|April 17, 2001
Familial aggregation of Parkinson's diseaseR de la Fuente-Fernández, D B Calne
Pageof 32

Showing results (81-90 of 315) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|March 2, 1989
Did Leonardo describe Parkinson's disease?D B Calne, A Dubini, G Stern
Annals of Neurology|December 1, 1992
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomaticM Schulzer, E Mak, D B Calne
Postgraduate Medical Journal|January 1, 1976
An ergot derivative in the treatment of Parkinson's diseaseD B Calne, I Shoulson, R Kartzinel
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1988
Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapyT A Hurwitz, D B Calne, K Waterman
Annals of Neurology|January 1, 1992
Criteria for diagnosing Parkinson's diseaseD B Calne, B J Snow, C Lee
Advances in Neurology|January 1, 1984
Speculations on the etiology of Parkinson's diseaseD B Calne, R C Duvoisin, E McGeer
Archives of Neurology|July 1, 1976
Bromocriptine in Huntington choreaR Kartzinel, R D Hunt, D B Calne
Acta Neurologica Scandinavica|November 1, 1982
Atenolol vs. propranolol in essential tremor. A controlled, quantitative studyT A Larsen, H Teräväinen, D B Calne
Advances in Neurology|January 1, 1988
Botulinum toxin in spasmodic torticollisJ K Tsui, A Eisen, D B Calne
The New England Journal of Medicine|April 17, 2001
Familial aggregation of Parkinson's diseaseR de la Fuente-Fernández, D B Calne
Pageof 32